Contemporary OB/GYN/LinkedIn
Jan 18, 2026, 07:48
DSMB Review Confirms Safety of Brexanolone for PPD – Contemporary OB/GYN
Contemporary OB/GYN shared a post on LinkedIn:
“A phase 3 trial of Lipocine Inc.‘s oral formulation of brexanolone, LPCN 1154, for postpartum depression, will continue without any modification following the completion of a second independent Data Safety Monitoring Board review.
In the second and last review, the DSMB found no safety concerns in the trial.
More details and more on the makeup of the trial.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 16, 2026, 13:30Simon Meagher and Rabih Chaoui Discuss Fetal Heart Scanning in the Latest ISUOG Podcast – ISUOG
-
Mar 16, 2026, 12:58Exploring the Link Between Adenomyosis and Proliferative Endometrial Disorders – Fertility and Sterility
-
Mar 16, 2026, 12:55Nicola Pozzi: A New Mechanism to Reduce Thrombus Formation Without Increasing Bleeding Risk
-
Mar 16, 2026, 12:44Endometriosis Awareness Month Virtual Issue! – ISUOG
-
Mar 16, 2026, 12:30Jeanne Conry: When the Government Intervenes, Women Die
-
Mar 16, 2026, 12:23Magdalena Simonis Highlights the Need to Change the Rhetoric on Endometriosis
-
Mar 16, 2026, 12:00Julia Chain Highlights Fertility Preservation as Part of Women’s Health Campaign – HFEA
-
Mar 15, 2026, 15:26Watching Life Begin: Scientists Track Embryo Implantation in Real Time! – Science Magazine
-
Mar 15, 2026, 15:03Reem Abu-Rustum Spotlights Fetal Situs in New ISUOG Quiz – ISUOG